Fundz

Cofactor Genomics reported raising $1.17 Million in an initial SEC Form D filing, from an offering of $2 Million

PRIVATEAug 02, 2023$1.2M of $2M raised

Amount Raised

$1.17 Million

$1.17 Million sold, per SEC Form D (first sale Jul 20, 2023)

Round Type

Seed

St. LouisBiotechnology

Who to call at COFACTOR GENOMICS, INC., and when

A new round usually means COFACTOR GENOMICS, INC. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day COFACTOR GENOMICS, INC. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at COFACTOR GENOMICS, INC., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at COFACTOR GENOMICS, INC.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

COFACTOR GENOMICS, INC.

Location

4044 CLAYTON AVENUE

St. Louis, Missouri, United States

About

Cofactor Genomics’s mission is to create diagnostics that have the ability to predict the patients that can benefit from immunotherapies. Using more insightful multidimensional biomarkers created with RNA and machine learning, Cofactor’s diagnostics offer greater predictive power than any current test. Instead of searching for isolated, single-analyte biomarkers or DNA mutations, Cofactor’s products create multidimensional biomarkers that better capture the complex immune response at the site of a tumor. Cofactor Genomics empowers clinicians to be better informed while making treatment decisions to improve patient outcomes.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment COFACTOR GENOMICS, INC. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsDavid M., Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for COFACTOR GENOMICS, INC.'s next move

See what Strategic adds

COFACTOR GENOMICS, INC. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.